Madison Square Garden Entertain (MSGE) Stock Price & How to Invest

Madison Square Garden Entertainment was separated from Sphere Entertainment Co. in April 2023 and kept the traditional venue portfolio: Madison Square Garden Arena, the smaller theater inside the Garden complex, Radio City Music Hall, the Beacon Theatre in New York and the Chicago Theatre. It earns money three ways. It books concerts, comedy, family shows and special events into those rooms and keeps ticketing economics, food and beverage and merchandise. It sells arena-level sponsorships and premium hospitality including suites, with partners such as Lexus, whose deal was expanded in 2026. And it collects long-dated license fees from Madison Square Garden Sports, a separate Dolan-controlled public company, for the New York Knicks and New York Rangers to play their home games at the Garden under agreements that run into the 2050s with annual escalators. The Christmas Spectacular is the single largest owned production, running roughly ~200 performances in a compressed holiday window and delivering a record run in the season that ended in the December 2025 quarter.

The investment picture has two separate pieces that are easy to conflate. The operating business is growing but not dramatically: revenue over the nine months ended March 2026 was ~$865 million, up ~10% year over year, while the March quarter itself grew only ~2% to ~$246 million and adjusted operating income fell ~20% to ~$46 million on higher event-related costs. The second piece is the reason the stock roughly doubled from a ~$35 low to the high ~$70s over the past year: in 2026 MSGE was named part of Penn Transformation Partners, the Halmar International and Skanska consortium selected for the Penn Station overhaul, and signed a non-binding memorandum of understanding under which the arena stays fully operational while the smaller theater could transfer to the master developer. Goldman Sachs has argued the market has under-appreciated several hundred million dollars of potential real-estate and air-rights monetization there. At ~75x trailing earnings, a meaningful share of the current price rests on that second piece rather than on ticket sales.

Almost everything MSGE owns sits in a few blocks of Manhattan, so a New York-specific shock to tourism, transit, labor costs or discretionary spending hits the whole portfolio at once. The cost base is largely fixed, which cuts both ways: the March 2026 quarter showed operating income down ~41% on revenue up ~2%, a reminder of how thin the margin cushion is when event costs rise faster than ticket revenue. Content supply is not owned, so the arena depends on Live Nation, AEG and other promoters routing tours through New York on acceptable terms. Governance is concentrated: the Dolan family controls the company through super-voting Class B shares, and the arena license agreements and other arrangements are with related Dolan-controlled entities, which limits outside shareholders' leverage over how value gets allocated. Finally, the Penn Station optionality that drove the last year of gains is a non-binding memorandum subject to public agencies, funding and multi-year construction that could disrupt the arena's own operations, and a stock at ~75x trailing earnings has little room if that process stalls.

7 analysts publish price targets on MSGE, averaging $80.71 against a $76.55 price as of August 2026, or +5.4%. The published targets run from $75.00 to $86.00, a narrow spread, and the ratings split 4 buy, 5 hold, 0 sell. Over the last six months there have been 7 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full MSGE forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Madison Square Garden Entertain. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. The Garden's booking calendar. Concert volume at Madison Square Garden Arena rose through fiscal 2026 and management described demand for live events as remaining strong heading into the June quarter. The most optimistic published target, $86.00, assumes this works close to its best case.

The case against. Almost everything MSGE owns sits in a few blocks of Manhattan, so a New York-specific shock to tourism, transit, labor costs or discretionary spending hits the whole portfolio at once. The most pessimistic target, $75.00, is roughly what MSGE is worth if this bites instead.

Read the full bull and bear case on MSGE, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Madison Square Garden Entertain's investor relations page or your broker.

• Revenue (TTM): ~$1.02 billion, up ~4.5%
• Fiscal Q3 2026 revenue (quarter ended March 31, 2026): ~$246 million, up ~2%
• Fiscal Q3 2026 adjusted operating income: ~$46 million, down ~20%
• EPS (TTM): ~$1.02, on net income of ~$49 million
• Market cap: ~$3.6 billion at ~$77 per share
• Debt: ~$622 million, including a ~$602 million term loan

Reported net income is a weak read on these venues: depreciation on decades-old real estate and interest on the term loan both sit above the line, which is why management guides to adjusted operating income instead. The shape of the year matters as much as the total, since the December quarter carries the Christmas Spectacular and generated ~$460 million of the ~$865 million booked over the first nine months of fiscal 2026. Fiscal fourth-quarter and full-year results for the year ended June 30, 2026 were scheduled for August 12, 2026, with management saying through the March quarter that it remained on track for growth in both revenue and adjusted operating income.

Other names that sit close to MSGE: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get MSGE exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so MSGE sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where MSGE fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

MSGE is a small, concentrated bet on New York venue real estate and a booking calendar, where the last year of share-price gains came less from the events business than from what the land under the arena might be worth.

Whether MSGE is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MSGE a buy or a sell?, and where the stock could go from here in the MSGE stock forecast.

For income investors, whether MSGE pays a dividend and how the payout looks is covered in does MSGE pay a dividend? And to weigh MSGE against a peer, read the full side-by-side comparisons: MSGE vs BCS and MSGE vs SPHR.